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Factors to Predict Positive Results of Gonadotropin Releasing 
Hormone Stimulation Test in Girls with Suspected Precocious 
Puberty
Sometimes, the clinical findings and the results of the gonadotropin-releasing hormone 
(GnRH) stimulation test are inconsistent in girls with early breast development and bone age 
advancement. We aimed to investigate the factors predicting positive results of the GnRH 
stimulation test in girls with suspected central precocious puberty (CPP). We reviewed the 
records of 574 girls who developed breast budding before the age of 8 yr and underwent 
the GnRH stimulation test under the age of 9 yr. Positive results of the GnRH stimulated 
peak luteinizing hormone (LH) level were defined as 5 IU/L and over. Girls with the initial 
positive results (n = 375) showed accelerated growth, advanced bone age and higher serum 
basal LH, follicle-stimulating hormone, and estradiol levels, compared to those with the 
initial negative results (n = 199). Girls with the follow-up positive results (n = 64) showed 
accelerated growth and advanced bone age, compared to those with the follow-up negative 
results. In the binary logistic regression, the growth velocity ratio was the most significant 
predictive factor of positive results. We suggest that the rapid growth velocity is the most 
useful predictive factor for positive results in the GnRH stimulation test in girls with 
suspected precocious puberty.
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INTRODUCTION
Idiopathic central precocious puberty (CPP) is the result of pre-
mature activation of the hypothalamic-pituitary-gonadal (HPG) 
axis, not related to intracranial pathology (1). In girls, precocious 
puberty is defined by the development of sexual characters, 
such as breast budding, before the age of 8 yr (2). CPP in girls is 
related to multiple problems, including inappropriate behavior, 
early pregnancy, and decreased final height by early epiphyseal 
fusion (3-5). Therefore, it is necessary to be timely diagnosed 
and promptly treated.
  Because the appearance of clinical pubertal symptoms is not 
synonymous with precocious puberty, it is necessary to identify 
the patients who need further evaluation for the potential to 
become precocious puberty. In children showing clinical signs 
of puberty, the pubertal process may stall or even revert and re-
sume at a later point (6). So far, the standard test used to verify 
the HPG activity has been the gonadotropin response to ad-
ministered gonadotropin-releasing hormone (GnRH) stimula-
tion (7, 8). However, the GnRH stimulation test requires an in-
travenous line and takes a long time for multiple blood sam-
ples. Sometimes it has to be measured several times, due to low 
sensitivity, despite its high specificity.
  Both the advancement of bone age and the pubertal response 
to gonadotropins may not occur in the initial stage of CPP. Thus, 
some cases have been diagnosed with CPP by GnRH stimula-
tion test during the follow-up period. In addition, breast caused 
by accumulation of fat was increasingly difficult to be distin-
guished from the breast areolar development, as the prevalence 
of obesity in children increased lately.
  In clinical settings, we may consider for whom and when the 
GnRH stimulation test is helpful. Some previous studies report-
ed differences between the CPP and premature thelarche, but 
they just compared data based on the final result of the GnRH 
stimulation test.
  In this study, in girls with suspected precocious puberty, we 
compared the clinical and laboratory characteristics depending 
on the results of the GnRH stimulation test recorded at the ini-
tial measure and at follow-up, and investigated the factors pre-
dicting positive results of the GnRH stimulation test.
MATERIALS AND METHODS
Subjects
We retrospectively analyzed the records of 574 girls who visited 
the Pediatric Endocrinology Clinic at Korea University Hospital Nam HK, et al.  •  GnRH Stimulation Test in Precocious Puberty Girls
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for the evaluation of early pubertal signs, from March 2005 to 
May 2010. The inclusion criteria were, as follows: 1) female with 
early breast development corresponding to Tanner stage B2 or 
above, before the age of 8 yr; 2) bone age 1 yr beyond chrono-
logical age; 3) GnRH stimulation test performed before the age 
of 9 yr; 4) followed for at least 6 months and followed up over 
the age of 9 yr old. Girls with any other endocrine disorders or 
with intracranial lesions detected by magnetic resonance imag-
ing were excluded.
  CPP was diagnosed on the appearance of secondary sexual 
maturation under the age of 8 yr and bone age advancement, 
accompanied by the pubertal peak luteinizing hormone (LH) 
level ≥ 5 IU/L. Results from each of the initial and follow-up 
GnRH stimulation tests were divided into two groups, based on 
the peak LH levels: below 5 IU/L (negative) or 5 IU/L and over 
(positive).
Methods
We retrospectively reviewed the chronological age, bone age, 
height, weight and body mass index (BMI, kg/m
2) at the initial 
GnRH stimulation test and laboratory profiles. Height and body 
weight were expressed as standard deviation score (SDS) for the 
same chronological age of Korean girls. Growth velocity ratio 
was calculated as growth velocity over 6 months divided by the 
average 6-month growth velocity of Korean girls for obtaining 
the growth velocity ratio. The average growth velocity of Korean 
girls was obtained from the height curves published in the 2007 
Korean National Growth Charts (9). And growth velocity over 6 
months was calculated as the difference in height between the 
height measured on the day when GnRH stimulation test was 
done. Follow-up GnRH stimulation test was done according to 
pubertal progress and growth velocity every 3 or 6 months. 
  The degree of breast development was rated according to the 
Marshall-Tanner stage. Bone age was assessed according to the 
Greulich-Pyle method, by taking the left hand and wrist radio-
graph. The predicted adult height (PAH) was determined ac-
cording to the Bayley-Pinneau method and, after subtracting 
the average height (160.4 cm) of 20-yr-old Korean women, we 
divided the result by the average standard deviation (SD) (5) for 
the PAH SDS.
  Serum concentrations of basal LH and follicle-stimulating 
hormone (FSH) were measured using the immunofluorimetric 
assay kits (Diasource immunoassay, Louvain-la-Neuve, Bel-
gium). Estradiol (E2) and insulin-like growth factor-I (IGF-I) 
were measured with the radioimmuoassay kits (Siemns, Frim-
ley, Camberley, UK and Immunotech, Prague, Czech Republic, 
respectively). LH and FSH levels response to GnRH 100 μg (Rele-
fact LHRH, Handock, Korea) were assessed by collecting blood 
samples, just before the administration of GnRH and subse-
quently, at 30, 60, and 90 min.
Statistics
The SPSS software version 12.0 (SPSS Inc., Chicago, IL, USA) 
and the MedCalc software version 11.3 (MedCalc software, 
Mariakerke, Belgium) were used for statistical analyses. The in-
dependent t-test was performed to compare the clinical and 
biochemical parameters between the groups of negative and 
positive results. The binary logistic regression analysis was used 
to assess the factors correlating with the results of the GnRH 
stimulation test. The area under the receiver operating charac-
teristics curve (AUC) was used to assess the prediction capacity 
of the variable factors. All data were expressed as mean ± SD 
and P < 0.05 was considered statistically significant.
Ethics statement
This study was approved by the institutional review board of 
Korea University Hospital (IRB number AN11128). Informed 
consent was waived by the board. 
RESULTS
Clinical and auxological characteristics of all subjects
Total 574 girls were investigated, the mean chronological age at 
the initial GnRH stimulation test was 8.0 ± 0.7 yr, the mean bone 
age was 9.8 ± 1.0 yr and the difference between the mean bone 
age and the mean chronological age (BA-CA) was 22 ± 9 months. 
The height SDS was 1.4 ± 0.8, the body weight SDS was 1.5 ± 1.1 
and the mean BMI was 17.9 ± 2.3 kg/m
2. The mean growth ve-
locity over 6 months was 3.5 ± 0.8 cm (Table 1).
Comparison of clinical and biochemical characteristics 
between groups
In the initial GnRH stimulation test, 375 girls were diagnosed as 
CPP and the remaining 199 girls had negative results (i.e., peak 
LH levels below 5 IU/L). In 375 girls with the initial positive re-
sults, the chronological age and the height SDS were similar, 
but the BMI was lower (positive test group, 17.7 ± 2.1 kg/m
2 vs 
negative test group, 18.4 ± 2.5 kg/m
2, P < 0.001), BA-CA was in-
creased (22 ± 8 months vs 20 ± 9, P = 0.02), the growth velocity 
over 6 months was more accelerated (3.7 ± 0.9 cm vs 3.1 ± 0.7 
cm, P < 0.001), as was the growth velocity ratio (1.3 ± 0.3 vs 
Table 1. Clinical and auxological characteristics of all subjects
Variables Subjects (n = 574)
Chronological age (yr) 8.0 ± 0.7
Bone age (yr) 9.8 ± 1.0
BA-CA (month) 22 ± 9
Height SDS 1.4 ± 0.8
Body weight SDS 1.5 ± 1.1
BMI (kg/m
2) 17.9 ± 2.3
Growth velocity (cm/6 months) 3.5 ± 0.8
Data are presented as Mean ± SD. BA-CA, the difference between the bone age and 
the chronological age; SDS, standard deviation score; BMI, body mass index.Nam HK, et al.  •  GnRH Stimulation Test in Precocious Puberty Girls
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1.1 ± 0.3, P < 0.001) compared to the negative results group. 
And also the basal LH concentration was increased, as was the 
basal FSH concentration, the basal E2 concentration and the 
IGF-I concentration compared to the negative results group 
(Table 2).
  In the follow-up GnRH stimulation test, 64 girls (32%) of the 
initial negative results group were diagnosed as CPP. In those 
64 girls with the follow-up positive results, the height SDS, body 
weight SDS and BMI were similar, but the chronological age 
was younger (7.8 ± 0.6 yr vs 8.0 ± 0.7 yr, P = 0.01), BA-CA was 
increased (23 ± 9 months vs 19 ± 9 months, P = 0.01), the growth 
velocity over 6 months was more accelerated (3.2 ± 0.6 cm vs 
3.0 ± 0.7 cm, P < 0.001), as was the growth velocity ratio (1.2 ± 0.2 
vs 1.1 ± 0.3, P = 0.01) compared to those of 135 girls with the 
follow-up negative results. Significant differences were not 
found in the basal LH, basal FSH, basal E2, and IGF-I concen-
trations (Table 3).
The binary logistic regression analysis
The variables considered to be associated with the results, i.e., 
the height SDS, body weight SDS, PAH SDS, the growth velocity 
ratio, BA-CA, and the basal E2, LH, FSH, and IGF-I concentra-
tions, were adjusted using the binary logistic regression analysis.
  After adjustment performed on the variables of 574 girls in 
the initial GnRH stimulation test, 5 variables were associated 
with the positive results, as follows: the body weight SDS (odds 
ratio, 0.70; 95% confidence interval [CI], 0.526-0.931; P = 0.01), 
the growth velocity ratio (odds ratio, 10.71; 95% CI 4.294-26.728, 
P < 0.001), the basal LH concentration (odds ratio, 1.62; 95% CI 
1.113-2.364, P = 0.01), the basal FSH concentration (odds ratio, 
2.37; 95% CI 1.718-3.268, P < 0.001), and the IGF-I concentra-
tions (odds ratio, 1.01; 95% CI 1.004-1.010, P < 0.001) (Table 4). 
  In the follow-up GnRH stimulation test, after adjustment 
performed on the variables of 199 girls, only 1 variable was as-
Table 2. Clinical and biochemical characteristics of girls participating in the initial GnRH 
stimulation test   (n = 574)
Parameters
Initial positive group
(n = 375)
Initial negative group
(n = 199)
P value
Height SDS 1.4 ± 0.8 1.3 ± 0.8 0.09
Body weight SDS 1.4 ± 1.1 1.6 ± 1.2 0.02*
BMI (kg/m
2) 17.7 ± 2.1 18.4 ± 2.5 < 0.001*
Chronological age (yr) 8.1 ± 0.7 8.0 ± 0.7 0.06
Bone age (yr) 10.0 ± 1.0 9.7 ± 0.9 < 0.001*
BA-CA (month) 22 ± 8 20 ± 9 0.02*
Growth velocity 
   (cm/6 months)
3.7 ± 0.9 3.1 ± 0.7 < 0.001*
Growth velocity ratio 1.3 ± 0.3 1.1 ± 0.3 < 0.001*
Basal LH (IU/L) 1.2 ± 2.3 0.7 ± 0.8 < 0.001*
Basal FSH (IU/L) 2.7 ± 1.3 1.8 ± 0.8 < 0.001*
Basal E2 (pg/mL) 10.5 ± 8.4 9.1 ± 6.8 0.03*
IGF-I (ng/mL) 343 ± 120 259 ± 75 < 0.001*
*P < 0.05. Data are presented as Mean ± SD. SDS, standard deviation score; BMI, 
body mass index; BA-CA, the difference between the bone age and the chronological 
age; LH, luteinzing hormone; FSH, follicle-stimulating hormone; E2, estradiol; IGF-I, 
insulin-like growth factor-I. 
Table 3. Clinical and biochemical characteristics of girls participating in the follow-up 
GnRH stimulation test   (n = 199)
Parameters
Follow-up positive 
results group 
(n = 64)
Follow-up negative
results group 
(n = 135)
P value
Height SDS 1.3 ± 0.7 1.3 ± 0.8 0.42
Body weight SDS 1.7 ± 1.2 1.6 ± 1.2 0.37
BMI (kg/m
2) 18.3 ± 2.5 18.4 ± 2.5 0.93
Chronological age (yr) 7.8 ± 0.6 8.0 ± 0.7 0.01*
Bone age (yr) 9.7 ± 0.9 9.6 ± 0.9 0.68
BA-CA (month) 23 ± 9 19 ± 9 0.01*
Growth velocity for  
6 months (cm)
3.2 ± 0.6 3.0 ± 0.7 < 0.001*
Growth velocity ratio 1.2 ± 0.2 1.1 ± 0.3 0.01*
Basal LH (IU/L) 0.7 ± 0.7 0.6 ± 0.8 0.76
Basal FSH (IU/L) 1.9 ± 0.9 1.7 ± 0.8 0.10
Basal E2 (pg/mL) 8.8 ± 4.3 9.2 ± 7.7 0.60
IGF-I (ng/mL) 268 ± 77 256 ± 74 0.38
*P < 0.05. Data are presented as Mean ± SD. SDS, standard deviation score; BMI, 
body mass index; BA-CA, the difference between the bone age and the chronological 
age; LH, luteinzing hormone; FSH, follicle-stimulating hormone; E2, estradiol; IGF-I, 
insulin-like growth factor-I.
Table 4. The binary logistic regression analysis of the factors associated with the results 
of the initial GnRH stimulation test
Factors* Odds ratio
95% Confidence  
 interval
P value
Height SDS 1.57 0.832-2.946 0.16
Body weight SDS 0.70 0.526-0.931 0.01
Growth velocity ratio 10.71 4.294-26.728 < 0.001
BA–CA (month) 1.01 0.971-1.058 0.54
Basal E2 (pg/mL) 1.01 0.947-1.074 0.79
Basal LH (IU/L) 1.62 1.113-2.364 0.01
Basal FSH (IU/L) 2.37 1.718-3.268 < 0.001
IGF-I (ng/mL) 1.01 1.004-1.010 < 0.001
*Factors of the initial positive results group (n = 375) were compared to those of the 
initial negative results group (n = 199). SDS, standard deviation score; BA-CA, the 
difference between the bone age and the chronological age; E2, estradiol; LH, luteinz-
ing hormone; FSH, follicle-stimulating hormone; IGF-I, insulin-like growth factor-I.
Table 5. The binary logistic regression analysis of the factors associated with the results 
of the follow-up GnRH stimulation test
Factors* Odds ratio
95% Confidence  
interval
P value
Height SDS 0.63 0.235-1.707 0.37
Body weight SDS 1.28 0.848-1.925 0.24
Growth velocity ratio 6.58 1.497-28.939 0.01
BA-CA (month) 1.06 0.996-1.137 0.07
Basal E2 (pg/mL) 0.86 0.452-1.632 0.64
Basal LH (IU/L) 1.46 0.940-2.276 0.09
Basal FSH (IU/L) 0.98 0.874-1.102 0.75
IGF-I (ng/mL) 1.00 0.999-1.009 0.15
*Factors of the follow-up positive results group (n = 64) were compared to those of 
the follow-up negative results group (n = 135). SDS, standard deviation score; BA-
CA, the difference between the bone age and the chronological age; E2, estradiol; 
LH, luteinzing hormone; FSH, follicle-stimulating hormone; IGF-I, insulin-like growth 
factor-I.Nam HK, et al.  •  GnRH Stimulation Test in Precocious Puberty Girls
http://jkms.org   197 http://dx.doi.org/10.3346/jkms.2012.27.2.194
sociated with the positive results, i.e., the growth velocity ratio 
(odds ratio, 6.58; 95% CI 1.497-28.939, P = 0.01) (Table 5).
Sensitivity and specificity of the growth velocity ratio
AUC was used to determine the predictive value of the growth 
velocity ratio for the positive results of GnRH stimulation test in 
suspected precocious puberty girls (AUC, 0.7; 95% CI 0.65-0.74, 
P < 0.001). The statistically optimal cut point of the growth ve-
locity ratio levels was 1.4, with a sensitivity of 36% and a speci-
ficity of 91%. Since the majority of girls (n = 512) in this study 
were aged 7-8 yr and had the same mean growth velocity, the 
AUC was also used to determine the predictive value of the 
growth velocity in suspected precocious puberty girls aged 7-8 
yr (AUC, 0.7; 95% CI 0.64-0.72, P < 0.001). The cut point of the 
growth velocity levels to predict the positive results of the GnRH 
stimulation test was 3.8 cm over 6 months, with a sensitivity of 
37% and a specificity of 90% (Fig. 1).
DISCUSSION
Based on the results of this study, girls diagnosed with CPP at 
the initial GnRH stimulation test had more accelerated growth, 
advanced bone age and higher serum basal LH, basal FSH and 
E2 concentrations, compared to those who showed pre-puber-
tal response on the GnRH stimulation test. In the binary logistic 
regression, the growth velocity ratio was the most significant 
predictive factor of positive results. 
  Globally, there is a secular trend towards earlier pubertal tim-
ing, especially in girls. According to the report from the Pediat-
ric Research in Office Settings network, conducted for 17,077 
US girls in 1997, the mean age of breast development was 9.96 
yr (10). In 2006, the mean age of menarche in Korean girls was 
12 yr. The mean age at menarche has advanced approximately 
by 2 yr between 1900 and 1980 birth cohorts (11).
  With a downwards secular trend in pubertal timing, the num-
ber of girls visiting the pediatric endocrinology clinic for the 
evaluation of early pubertal sign is increasing. In a Korean south-
ern area, the number of girls diagnosed as precocious puberty 
has increased each yr from 25 in 2003 to 121 in 2006 (12). 
  The response to GnRH stimulation is still the gold standard 
for diagnosing precocious puberty. However, in some cases, the 
clinical characteristics and the results of the GnRH stimulation 
test are inconsistent. Because of difficulties with frequent sam-
pling and time-consuming, we may consider for whom and 
when the GnRH stimulation test is helpful.
  In this study, the features of all 574 investigated girls, such as 
early breast development, advanced bone age over chronologi-
cal age, tall stature and rapid growth, were similar with the char-
acteristics of precocious puberty. Among them, 375 girls were 
diagnosed as CPP in the initial GnRH stimulation test. The ini-
tial positive group had lower BMI, increased BA-CA, accelerat-
ed growth velocity, and elevated basal LH, basal FSH, basal E2 
and IGF-I levels, compared to the initial negative results group. 
  Della Manna et al. (13) also reported tall stature, accelerated 
growth rate and bone age, increased uterine and ovarian vol-
umes, and high spontaneous LH levels in the precocious pu-
berty group. They found the growth velocity below the 90th 
percentile in 78% of idiopathic premature thelarche patients, 
whereas in the precocious puberty group, 76% were girls with 
90th percentile. They mentioned the differences of clinical and 
biochemical characteristics between two groups, but did not 
investigate the correlation. The increase in yearly growth rate, 
bone age advancement, high level of serum basal LH, GnRH-
stimulated peak LH and peak FSH were also significant in Ko-
rean children diagnosed as precocious puberty (14).
  In this study, we used the term ‘growth velocity ratio’ for ad-
justing the differences of growth velocity according to age. In 
the binary logistic regression analysis, the growth velocity ratio 
was the most significant predictive factor of positive results. The 
study of Utriainen et al. (15) also reported accelerated growth in 
girls with premature adrenarche.
  Several previous observations have found a positive associa-
tion between increased body mass index and earlier pubertal 
maturation (16, 17), whereas another study reported that the 
early increase in height seemed to be independent of the weight 
gain (15). The relationship between weight gain and precocious 
puberty was not proven yet. In our study, differences in the mean 
BMI between the initial two groups were observed, but both 
values were within the normal range. In addition, some of the 
breast enlargement seen in girls with the initial negative results 
was thought to be adiposity due to weight gain, not the onset of 
Fig. 1. Receiver operating characteristic curve for the growth velocity of girls with 
suspected precocious puberty. It shows the optimal cut point to predict the positive 
result of the GnRH stimulation test. The small closed circle indicates the growth veloc-
ity of 3.8 cm over 6 months (sensitivity 37%, specificity 90%). 
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puberty. 
  Previous studies tried to differentiate girls with precocious 
puberty from girls with premature thelarche. Houk et al. (8) and 
Cho et al. (18) suggested the basal LH level may express the ac-
tivity of the pubertal HPG axis in most CPP girls. However, this 
was limited by the intermittent and nocturnal pattern of the LH 
secretion and by the variability of immunoassay results obtained 
from different laboratories (19). Other previous studies suggest-
ed that the IGF-I level was increased in girls with CPP, compared 
to those with premature thelarche (20-22). Another study sug-
gested that the peak LH level after GnRH stimulation test was 
useful, therefore, girls with early breast budding and peak LH 
values between 3.5 and 4.5 IU/L should be carefully followed-
up (23). 
  Early breast development is the first stage of puberty, in both 
premature thelarche and precocious puberty. Therefore, girls 
with either spontaneous regression of breast development or 
progression to precocious puberty should be carefully followed-
up (24).
  In the follow-up GnRH stimulation test, 32% of girls with the 
initial negative results were diagnosed with CPP. Girls with the 
positive results at follow-up had accelerated growth and in-
creased BA-CA, compared to those with negative results at fol-
low-up test. There were no significant differences in the BMI, 
and the basal LH, basal FSH, basal E2 and IGF-I levels between 
the two groups. Only the growth velocity ratio was proved to be 
useful in predicting the positive result of the GnRH stimulation 
test. It was not easy to differentiate CPP from girls with the ini-
tial negative results, due to similar clinical and laboratory char-
acteristics between the groups. Our data suggested that the pre-
cise evaluation of growth velocity is necessary to determine 
which girls may require the follow-up GnRH stimulation test 
and may need GnRH agonist treatment.
  We used the receiver operating characteristic (ROC) curve to 
confirm the predictive value of the growth velocity ratio for the 
positive results of the GnRH stimulation test. The AUC showed 
prediction capacity for the growth velocity ratio to diagnose CPP. 
The statistically optimal cut point of the growth velocity ratio 
levels was 1.4. Since the majority of girls (n = 512) in this study 
were aged 7-8 yr and had the same mean growth velocity, the 
AUC was also used to determine the predictive value of the 
growth velocity in suspected precocious puberty girls aged 7-8 
yr (AUC, 0.7; 95% CI 0.64-0.72, P < 0.001). The cut point of the 
growth velocity levels to predict the positive results of the GnRH 
stimulation test was 3.8 cm over 6 months, with a sensitivity of 
37% and a specificity of 90%.
  There are some limitations for growth velocity to apply in 
clinical practice because growth velocity has a low sensitivity as 
a screening and it takes at least 3 to 6 months to be assessed. 
However, it could be useful to avoid unnecessary tests due to 
high specificity and to decide the appropriate timing for the fol-
low-up test especially of those girls with initial negative results 
of GnRH stimulation test.
  In conclusion, CPP girls with positive results of the GnRH 
stimulation test show increased bone age, rapid growth and in-
creased gonadotropin levels. It suggests that the rapid growth 
velocity is the most useful predictive factor for positive results in 
the GnRH stimulation test when deciding the timing of the test.
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